386 related articles for article (PubMed ID: 22410316)
1. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Banasikowski TJ; Beninger RJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors.
Banasikowski TJ; Beninger RJ
Int J Neuropsychopharmacol; 2012 Nov; 15(10):1525-34. PubMed ID: 22093169
[TBL] [Abstract][Full Text] [Related]
3. A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.
Audinot V; Newman-Tancredi A; Gobert A; Rivet JM; Brocco M; Lejeune F; Gluck L; Desposte I; Bervoets K; Dekeyne A; Millan MJ
J Pharmacol Exp Ther; 1998 Oct; 287(1):187-97. PubMed ID: 9765337
[TBL] [Abstract][Full Text] [Related]
4. Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.
Banasikowski TJ; Bespalov A; Drescher K; Behl B; Unger L; Haupt A; Schoemaker H; Sullivan JP; Gross G; Beninger RJ
J Pharmacol Exp Ther; 2010 Nov; 335(2):506-15. PubMed ID: 20724485
[TBL] [Abstract][Full Text] [Related]
5. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes.
Sheppard B; Lehmann J; Cope ZA; Brown RW
Behav Neurosci; 2009 Dec; 123(6):1296-308. PubMed ID: 20001113
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nafadotride, CNQX, and haloperidol on acquisition versus expression of amphetamine-conditioned place preference in rats.
Banasikowski TJ; MacLeod LS; Beninger RJ
Behav Pharmacol; 2012 Feb; 23(1):89-97. PubMed ID: 22157177
[TBL] [Abstract][Full Text] [Related]
8. Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.
Filip M; Papla I; Czepiel K
Pol J Pharmacol; 2002; 54(6):687-91. PubMed ID: 12866725
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic mechanisms underlying catalepsy, fear and anxiety: do they interact?
Colombo AC; de Oliveira AR; Reimer AE; Brandão ML
Behav Brain Res; 2013 Nov; 257():201-7. PubMed ID: 24120401
[TBL] [Abstract][Full Text] [Related]
10. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
12. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
13. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
Khisti RT; Deshpande LS; Chopde CT
Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
[TBL] [Abstract][Full Text] [Related]
14. Post-trial dopaminergic modulation of conditioned catalepsy: A single apomorphine induced increase/decrease in dopaminergic activation immediately following a conditioned catalepsy response can reverse/enhance a haloperidol conditioned and sensitized catalepsy response.
Oliveira LR; Dias FRC; Santos BG; Silva JLL; Carey RJ; Carrera MP
Behav Brain Res; 2016 Sep; 311():87-98. PubMed ID: 27173428
[TBL] [Abstract][Full Text] [Related]
15. Central effects of nafadotride, a dopamine D3 receptor antagonist, in rats. Comparison with haloperidol and clozapine.
Kuballa G; Nowak P; Labus Ł; Bortel A; Dabrowska J; Swoboda M; Kwieciński A; Kostrzewa RM; Brus R
Pharmacol Rep; 2005; 57(2):161-9. PubMed ID: 15886414
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of haloperidol in the mediation of conditioned fear in the mesolimbic system and processing of unconditioned aversive information in the inferior colliculus.
Muthuraju S; Nobre MJ; Saito VM; Brandao ML
Neuroscience; 2014 Mar; 261():195-206. PubMed ID: 24384225
[TBL] [Abstract][Full Text] [Related]
17. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
Rogóz Z; Skuza G
Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine D3 receptor antagonists on spontaneous and agonist-reduced motor activity in NMRI mice and Wistar rats: comparative study with nafadotride, U 99194A and SB 277011.
Gyertyán I; Sághy K
Behav Pharmacol; 2004 Jul; 15(4):253-62. PubMed ID: 15252275
[TBL] [Abstract][Full Text] [Related]
19. The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats.
Gyertyán I; Sághy K
Eur J Pharmacol; 2007 Oct; 572(2-3):171-4. PubMed ID: 17628535
[TBL] [Abstract][Full Text] [Related]
20. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Maj J; Rogóz Z; Skuza G
J Neural Transm (Vienna); 1999; 106(11-12):1063-73. PubMed ID: 10651103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
